K-pop

Still Going Strong After 4 Years… Kids’ “Tom Boy” Music Video Hits 400 Million Views

Third Record Following 'Queen' and 'Nude'

YUN GI BACK
2026-08-08 10:57:09
[Edaily Starin YUN GI BACK Reporter] The music video for the group i-dle’s hit song “TOMBOY” has surpassed 400 million views, once again proving its global popularity.
(Photo courtesy of Cube Entertainment)

According to their agency, Cube Entertainment, i-dle’s “TOMBOY” music video surpassed 400 million views on YouTube on the 7th. With this achievement, i-dle now has their third music video to reach 400 million views, following “Queen” and “Nude.”
“Tom Boy” is the title track from their first full-length album, *I Never Die*, released in 2022, and has established itself as one of iKID’s signature hits. At the time, it sparked a phenomenon by achieving a “Perfect All-Kill” on major domestic music charts and was recognized for both its artistic merit and mass appeal by topping Billboard’s list of “Best K-Pop Songs of 2022.”
It is noteworthy that even now, four years after its release, the song continues to enjoy long-term popularity, steadily increasing its view count. It is widely regarded as having transcended a fleeting trend to become one of IZ*ONE’s signature pieces, garnering sustained interest from global fans.
iKIDZ has music videos that have surpassed 200 million views—such as “Ratata” and “Oh My God”—as well as numerous videos with over 100 million views, including “Han,” “Ryan,” “Hwa,” “Super Lady,” and “Allergy.” Analysts note that, backed by this robust catalog, the group is demonstrating the sustained spending power of its global fanbase.

Economy

Corporation

IT·Science

Economy

[Exclusive] HANWHA SOLUTIONS Transfers ‘Hanwha Simaron’ to Hanwha Defense… Expects Financial Improvement and Synergies

HANWHA SOLUTIONS(009830)It has been confirmed that Hanwha Solutions has sold its U.S.-based high-pressure tank manufacturing subsidiary, “Hanwha Cimarron LLC,” to Hanwha Defense USA, the U.S. defense …
2026-11-13 15:37:03

Corporation

Burdened by Raw Material and One-Time Costs… Pulmuone Corporate’s Third-Quarter Operating Profit Down 89.6%

Pulmuone Corporate’s operating profit for the third quarter of this year fell to one-tenth of the level recorded in the same period last year. Although sales increased, profitability in its domestic b…
2026-11-13 16:40:27

IT·Science

HANDOK Inc.: Partner Company’s Rare Hypoglycemia Treatment Set to Draw Attention This Year… Results of External Collaboration Put to the Test

Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…
2026-11-13 15:42:02